ALKERMES | ALKS - 营业利润

金融业

USD 44.32

USD 4.39B

现金及等价物

USD 511.53M

USD 120.7M

USD 1.52B

USD 662.09M

USD 1.58B

股息收益率

0

USD -65.93M

USD 139.22M

1.8K

EPS每股收益

USD 0

股本和储备

USD 1.81B

USD 375.31M

债务利息支出

USD 25.93M

USD 8.54M

USD 1.48B

USD 7.19B

USD 501K

USD 1.81B

USD -65.93M

普通股股本

USD 167.54M

135.81

USD -61.93M

USD 496.01M

销售和管理费用

USD 196.64M

USD 298.96M

贸易债权人

USD 142.86M

应收帐款人

USD 456.48M

	营业利润	更改		日
AbbVie	USD 6.72B		1.99B	2026-06
Acadia Pharmaceuticals	USD 37.84M		42.45M	2026-06
ALKERMES	USD -65.93M		17.65M	2026-06
Amgen	USD 4.61B		777M	2026-06
Biogen	USD -243.8M		758.1M	2026-06
BioMarin Pharmaceutical	USD 105.6M		24.04M	2026-06
Bristol-Myers Squibb	USD 299M		3.07B	2026-06
Coherus Biosciences	USD -39.08M		3.65M	2025-12
Eli Lilly	USD 12.46B		2.68B	2026-06
Gilead Sciences	USD 3.85B		1.17B	2026-06
Heron Therapeutics	USD 38K		3.83M	2025-12
Ionis Pharmaceuticals	USD -102.29M		15.71M	2026-06
J&J	USD 6.47B		1B	2026-09
Malin Corporation	EUR -1.1M		400K	2024-12
Merck	USD 840M		2.72B	2026-06
Minerva Neurosciences	USD -21.85M		17.48M	2024-12
Nektar Therapeutics	USD -38.26M		19.17M	2026-03
Neurocrine Biosciences	USD 219.9M		5.3M	2026-06
Otsuka Holdings	JPY 140.41B		22.2B	2026-06
Ovoca Bio	EUR -173K		990K	2025-12
Pfizer	USD 667M		4.32B	2026-06
Regeneron Pharmaceuticals	USD 1.42B		675.7M	2026-06
Vertex Pharmaceuticals	USD 1.27B		129.9M	2026-06